Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Thorley-Lawson

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Current Topics in Microbiology and Immunology|October 2, 2015
EBV Persistence--Introducing the VirusDavid A Thorley-Lawson
The Journal of Allergy and Clinical Immunology|August 9, 2005
EBV the prototypical human tumor virus--just how bad is it?David A Thorley-Lawson
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2014
EBV microRNA BART 18-5p targets MAP3K2 to facilitate persistence in vivo by inhibiting viral replication in B cellsJin Qiu, David A Thorley-Lawson
The New England Journal of Medicine|March 27, 2004
Persistence of the Epstein-Barr virus and the origins of associated lymphomasDavid A Thorley-Lawson, Andrew Gross
Nature Medicine|August 8, 2007
Pathogens cooperate in lymphomagenesisDavid A Thorley-Lawson, Karen A Duca
Journal of Virology|December 23, 2004
Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivoLauri L Laichalk, David A Thorley-Lawson
Journal of Virology|February 6, 2009
The intersection of Epstein-Barr virus with the germinal centerJill E Roughan, David A Thorley-Lawson
Nature Reviews. Microbiology|November 15, 2008
The curious case of the tumour virus: 50 years of Burkitt's lymphomaDavid A Thorley-Lawson, Martin J Allday
Journal of Virology|September 28, 2007
Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoterChia Chi Sun, David A Thorley-Lawson
Methods in Molecular Biology (Clifton, N.J.)|October 28, 2004
Quantitative detection of viral gene expression in populations of Epstein-Barr virus-infected cells in vivoDonna R Hochberg, David A Thorley-Lawson
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Current Topics in Microbiology and Immunology|October 2, 2015
EBV Persistence--Introducing the VirusDavid A Thorley-Lawson
The Journal of Allergy and Clinical Immunology|August 9, 2005
EBV the prototypical human tumor virus--just how bad is it?David A Thorley-Lawson
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2014
EBV microRNA BART 18-5p targets MAP3K2 to facilitate persistence in vivo by inhibiting viral replication in B cellsJin Qiu, David A Thorley-Lawson
The New England Journal of Medicine|March 27, 2004
Persistence of the Epstein-Barr virus and the origins of associated lymphomasDavid A Thorley-Lawson, Andrew Gross
Nature Medicine|August 8, 2007
Pathogens cooperate in lymphomagenesisDavid A Thorley-Lawson, Karen A Duca
Journal of Virology|December 23, 2004
Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivoLauri L Laichalk, David A Thorley-Lawson
Journal of Virology|February 6, 2009
The intersection of Epstein-Barr virus with the germinal centerJill E Roughan, David A Thorley-Lawson
Nature Reviews. Microbiology|November 15, 2008
The curious case of the tumour virus: 50 years of Burkitt's lymphomaDavid A Thorley-Lawson, Martin J Allday
Journal of Virology|September 28, 2007
Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoterChia Chi Sun, David A Thorley-Lawson
Methods in Molecular Biology (Clifton, N.J.)|October 28, 2004
Quantitative detection of viral gene expression in populations of Epstein-Barr virus-infected cells in vivoDonna R Hochberg, David A Thorley-Lawson
Pageof 4